During neurogenesis, progenitors switch from self-renewal to differentiation through the interplay of intrinsic and extrinsic cues, but how these are integrated remains poorly understood. Here we combine whole genome transcriptional and epigenetic analyses with in vivo functional studies and show that Bcl6, a transcriptional repressor known to promote neurogenesis, acts as a key driver of the neurogenic transition through direct silencing of a selective repertoire of genes belonging to multiple extrinsic pathways promoting self-renewal, most strikingly the Wnt pathway. At the molecular level, Bcl6 acts through both generic and pathway-specific mechanisms. Our data identify a molecular logic by which a single cell-intrinsic factor ensures robustness of neural cell fate transition by decreasing responsiveness to the extrinsic pathways that favor self-renewal.
Summary
During neurogenesis, progenitors switch from self-renewal to differentiation through the interplay of intrinsic and extrinsic cues, but how these are integrated remains poorly understood. Here we combine whole genome transcriptional and epigenetic analyses with in vivo functional studies and show that Bcl6, a transcriptional repressor known to promote neurogenesis, acts as a key driver of the neurogenic transition through direct silencing of a selective repertoire of genes belonging to multiple extrinsic pathways promoting self-renewal, most strikingly the Wnt pathway. At the molecular level, Bcl6 acts through both generic and pathway-specific mechanisms. Our
Introduction
During neural development, the generation of the appropriate type and number of differentiated neurons and glial cells is controlled by a complex interplay between extrinsic and intrinsic cues acting on neural progenitors, which control the balance between differentiation and self-renewal (Martynoga et al., 2012; Rossi et al., 2017; Tiberi et al., 2012b) .
In the developing cortex, radial glial cells are the main progenitors that will differentiate into specific post-mitotic neuron populations directly or through various classes of intermediate progenitors (Gotz and Huttner, 2005;  Kriegstein and Alvarez-Buylla, 2009). Proneural transcription factors act on these progenitors as the main intrinsic drivers of neurogenesis (Guillemot and Hassan, 2017; Guillemot et al., 2006) , by directly inducing various classes of genes involved in neuronal differentiation and through cross-repression with the Notch pathway, which promotes self-renewal. Key features of the Notch signaling pathway including lateral inhibition and oscillatory behaviour, contribute to the irreversible commitment of differentiating cells towards neuronal fate (Kageyama et al., 2008) . In addition however, many classes of extrinsic morphogen cues, including Wnts, Sonic Hedgehog (SHH), and Fibroblast Growth Factors (FGF) can act on cortical progenitors to promote expansion and self-renewal, and thereby inhibit neurogenesis (Chenn and Walsh, 2002; Kang et al., 2009; Lien et al., 2006; Rash et al., 2011; Wang et al., 2016) .
Intriguingly, it has long been proposed that postmitotic cells ongoing neuronal differentiation become insulated from extrinsic signaling (Edlund and Jessell, 1999) , but the molecular mechanisms remain essentially unknown. Whether and how the negative modulation of responsiveness to extrinsic cues is required for neuronal commitment remains currently unclear, as are the underlying mechanisms. Delamination of the progenitors away from the ventricular zone could contribute to this process, as some of the morphogen cues are secreted in the embryonic cerebrospinal fluid and are thought to act through the apical processes or cilia of the radial glial cells (Lehtinen et al., 2011) . However several cues, most strikingly Wnts, are also present in the cortical tissue (Harrison-Uy and Pleasure, 2012) , where they can act on progenitors to block differentiation.
Moreover, the signaling components of these various pathways, as well as some key downstream targets, are often partially overlapping. For instance, cross-talk of the Notch and Wnt pathways (Hayward et al., 2008) , or Notch and FGFs (Rash et al., 2011) , has been documented during embryonic development and despite the relatively simple intracellular regulation of the Wnt/β-catenin pathway, many of its components are used by other pathways or participate in distinct cellular activities. For instance, the deletion of Gsk3a/b, a major intracellular component of the β-catenin destruction complex, increases the proliferation of radial glial cells at the expense of their differentiation by altering not only Wnt but also Notch and FGF signaling activity (Kim et al., 2009) . Also, some key effectors genes such as Cyclin d1/d2 are found as common targets of most morphogen pathways depending on cellular context (Cohen et al., 2010; Kalita et al., 2013; Katoh and Katoh, 2009; Nilsson et al., 2012; Shtutman et al., 1999) . How these intermingled pathways are effectively shut down during neurogenesis is therefore an important and complex issue that remains largely unresolved.
We previously reported that the transcriptional repressor Bcl6 (Baron et al., 1993; Chang et al., 1996) is required for neuronal differentiation in the cerebral cortex at least in part through repression of the Notch-dependent Hes5 target (Tiberi et al., 2012a) , while in the cerebellum, Bcl6 promotes neurogenesis through repression of SHH pathway effectors Gli1/2 (Tiberi et al., 2014) . This raises the question whether Bcl6 promotes neurogenic conversion through the repression of distinct targets depending on the cellular context, or through a more generic transcriptional repression programme.
Here we combine transcriptome, epigenome and in vivo functional analyses to determine the molecular logic of action of Bcl6 during neurogenesis, focusing on the cerebral cortex. We find that Bcl6 acts a global repressor of a repertoire of signaling components of most signaling pathways known to promote self-renewal, including Notch, SHH, FGFs, and most strikingly the Wnt pathway. These data define a molecular logic of neurogenesis whereby a single intrinsic factor can modulate negatively the responsiveness to several extrinsic cues, through transcriptional repression at multiple parallel and serial levels along their downstream pathways, to ensure irreversible neurogenic fate transition.
Results

Bcl6 upregulates an intrinsic neurogenic program and downregulates extrinsic proliferative pathways.
To determine the primary molecular mechanisms of Bcl6 action in cortical neurogenesis, we performed RNA-seq transcriptome analysis on in vitro embryonic stem cell-derived cortical progenitors driving inducible Bcl6 expression ( Figure 1A ; (Gaspard et al., 2008; Tiberi et al., 2012a) . We found that 24 hours following Bcl6 induction 764 genes were significantly upregulated, with Bcl6 being the most increased, and 610 genes were significantly down-regulated, with Hes5 being the most repressed (Supplementary Table S1 ).
Gene Ontology analysis of the up-regulated genes revealed a significant enrichment in categories linked to development and cell/neuron differentiation (Figure 1B, Supplementary Table S2 ). More specifically, most of the canonical markers of differentiation into intermediate progenitors and neurons were significantly up-regulated ( Figure 1C ; Supplementary Table S1 ). On the other hand, down-regulated genes showed an enrichment in gene categories linked to regulation of translation, negative regulation of neurogenesis, and most strikingly to signaling pathways promoting the expansion and self-renewal of cortical progenitors ( Figure 1B, Supplementary Table S2 ). Among the significantly down-regulated genes, we found as expected markers of radial glial cells and transcriptional targets of Notch, but also many signaling components of FGF and SHH-dependent pathways, and most strikingly a high number of genes belonging to the Wnt signaling cascade, from ligands to receptors to target genes (Figures 1C-E; Supplementary Tables S1 and S3 ).
This suggests that Bcl6 could act by repressing multiple proliferative pathways to promote neurogenesis.
Bcl6 functionally alters β-catenin signaling to promote neurogenesis
Given the importance of the Wnt pathway in the regulation of selfrenewal/differentiation balance in the cortex (Chenn and Walsh, 2002; Fang et al., 2013; Hirabayashi and Gotoh, 2005; Hirabayashi et al., 2004; Kuwahara et al., 2010; Munji et al., 2011; Mutch et al., 2010; Wrobel et al., 2007; Zhang et al., 2010) and the number of down-regulated genes belonging to this pathway, we tested the global impact of Bcl6 on the Wnt pathway in vivo. Axin 2, a classical Wnt/β-catenin-dependent target gene, was found to be upregulated in Bcl6 -/-mouse embryonic cortex using in situ hybridization. While
Axin2 expression is normally detected in the medial pallium of the frontal cortex in wild-type animals, a higher signal was found throughout dorsolateral levels in Bcl6 -/-mice ( Figure 2A -B), suggesting that β-catenin/Tcf activity is increased in the mutant cortex. Interestingly this difference was not detectable at more posterior levels ( Figure 2A -B) in accordance with the frontal high occipital low graded Bcl6 expression (Tiberi et al., 2012a) . These data suggest that Bcl6 neurogenic function could depend on the down-regulation of the canonical Wnt pathway. We first tested this in vitro by examining potential genetic interactions between Bcl6 and β-catenin, the main signaling hub protein of the pathway. Neurogenic genes up-regulated in vitro by Bcl6 were prevented by CHIR99021, a GSK3 inhibitor over-activating the canonical Wnt pathway. CHIR99021, which increased the levels of the Wnt reporter gene Lef1, also prevented Bcl6-mediated down-regulation of Wnt target genes but did not prevent repression of Notch targets (Supplementary Figure S1 ). We then examined in vivo the impact of the gain of function of a stabilized β-catenin mutant on Bcl6 overexpression using in utero electroporation ( Figure   2 ). Bcl6 gain of function led to an increased neurogenesis, as assessed by increased number of cells in the cortical plate (CP) and an increase in Tuj1+ neuronal cells at the expense of VZ-located-Pax6+ progenitors ( Figure 2C -E).
Importantly these effects were suppressed by overexpression of stabilized β-catenin.
Conversely, we combined Bcl6 and β-catenin (Ctnnb1) knockdown to assess potential epistasis. As expected (Tiberi et al., 2012a) , Bcl6 knockdown led to decreased neurogenesis, as assessed by increased cell number in the VZ at the expense of the CP ( Figure 2F -G) associated with increased levels of Pax6+ progenitors and decreased Tuj1+ neurons ( Figure 2H ). This phenotype was significantly rescued by the Ctnnb1 knock-down ( Figure 2F -H). These data suggest that Bcl6 functionally acts on the Wnt pathway to promote neurogenesis, in addition to its effect on the Notch target Hes5 (Tiberi et al., 2012a and Notch (Cohen et al., 2010) . Moreover, Cyclin d1/d2 are key promoters of cortical progenitor proliferation and consequently block neurogenesis (Lange et al., 2009; Pilaz et al., 2009; Tsunekawa et al., 2012) .
We first examined their expression in the developing cortex in wild-type and Bcl6 -/-brains. Ccnd1 was found in the VZ and SVZ in wild-type mice as previously reported (Glickstein et al., 2007) , and its levels were significantly increased in Bcl6 -/-animals ( Figure 3A -B). Ccnd2 mRNA was mostly detected in basal end-feet of radial glial cells and at lower intensity in the ventricular zone at E12.5, as previously described (Tsunekawa et al., 2012) . While the high density of labeling and limited resolution of in situ hybridization precluded to detect upregulation in the basal end-feet, Ccnd2 levels were significantly increased in the VZ in Bcl6 -/-cortex ( Figure 3C-D (Ciemerych et al., 2002; Glickstein et al., 2007; Tsunekawa et al., 2012) . Decreased neurogenesis observed following Bcl6 shRNA ( Figure 3E -G) was completely rescued by the dual Ccnd1/Ccnd2 knockdown ( Figure 3E-G) . This indicates that, in addition to repressing specific signaling pathway components, Bcl6 action also involves repression of common terminal effector targets driving progenitor proliferation and self-renewal.
Bcl6 down-regulates its target genes through generic as well as
pathway-specific mechanisms.
Overall our data indicate that Bcl6 acts through inhibition of multiple pathways to promote neurogenesis, raising the question of which effects are directly related to Bcl6 transcriptional repression, or reflect its indirect consequences.
To address this point, we performed ChIP-seq to identify Bcl6 binding sites in Further, 39% of the Bcl6 predicted targets (1701/4366 peak-associated genes) were similar to those previously reported by ChIP-seq in human B cells (Basso et al., 2010) . In line with our transcriptomics data, Bcl6 bound to numerous genes of the multiple cascades regulating the proliferation of cortical progenitors (Supplementary Figure S2E) Figure 1E ).
We next examined how Bcl6 binding to its target sequences might lead to transcriptional repression. We previously found that Bcl6-mediated Hes5 repression occurs through modifications of histone acetylation mediated by Sirt1 deacetylase recruitment (Tiberi et al., 2012a ). Remarkably we found a similar mechanism for all tested target genes identified above ( Figure 5 ).
Indeed, in vivo ChIP-qPCR experiments performed on mouse E12.5 embryonic cortex showed enrichment for acetylated lysines H4K16 and
H1.4K26 on all tested genes in Bcl6 -/-cortex compared with wild-type, indicating that repressive chromatin remodeling required the presence of Bcl6 binding ( Figure 5A , Supplementary Figure S3B ). Moreover, we detected binding of the histone deacetylase Sirt1 to all Bcl6-bound target genes, which was abolished in Bcl6 -/-cortex ( Figure 5B , Supplementary Figure S3C ).
These data point to a generic mechanism by which a wide repertoire of the genes down-regulated by Bcl6 and belonging to stem cell renewal signaling pathways are directly bound and repressed by Bcl6, which then recruits Sirt1, leading to their transcriptional silencing.
To test whether additional mechanisms that are signaling pathway-specific may be involved, we examined in more depth the mechanism of action of Bcl6 on Ccnd1/2. Bcl6 was found to bind to their regulatory regions in vitro,
together with Sirt1, in association with histone H4K16 deacetylation, as observed in vivo ( Figure 6 ). We then examined the binding profile of Tcf7l1
( Figure 6A -B), the only Wnt/β-catenin-associated Tcf/Lef transcription factor known to be expressed in cortical progenitors (Galceran et al., 2000) . Tcf7l1
was found to bind to both Ccnd1/2 promoters on predicted Tcf/Lef binding sites, confirming their direct link with the Wnt pathway ( Figure 6B ). Most strikingly, this binding was decreased upon Bcl6 overexpression ( Figure 6B ).
In contrast, Tcf7l1 binding at the level of the Lef1 promoter, to which Bcl6 does not bind to, was unaffected (Supplementary Figure S5) , suggesting that Bcl6 directly affects Tcf7l1 binding to Ccnd1/2 promoters.
These data suggest that Bcl6 has specific effects on the binding of other transcription factors to promoters, as an additional mechanism to modulate responsiveness to extrinsic pathways.
Discussion
Neurogenesis is a key fate transition controlled by the interplay of intrinsic and extrinsic cues, but how these are integrated at the molecular level remains poorly known. Here we show how a single transcriptional repressor, Bcl6, can promote fate conversion through the direct repression of a repertoire of genes encoding key components of numerous extrinsic morphogen pathways that promote self-renewal and proliferation. This provides important insight on the molecular logic by which neurogenic conversion can occur in a robust fashion in the presence of many, and sometimes contradictory, extrinsic cues.
Our transcriptome analysis shows that Bcl6 gain of function elicits a broad This global repressive effect is reminiscent of the one previously proposed for Myt1l in the frame of neuronal reprogramming, where a single transcription factor appears to repress globally multiple non-neuronal fates to promote in vitro conversion into neurons (Mall et al., 2017) or of Lola and Prospero that repress neural stem cell fate in fly neurons (Southall et al., 2014) . It is also strikingly complementary to the Rest complex, which represses neuronal fate genes in non-neuronal cells (Ballas et al., 2005) . In the case of Bcl6 however, our data suggest that its repression does not appear to act so much on fatespecific genes per se, but rather on genes selectively involved in responsiveness to extrinsic signaling pathways promoting progenitor maintenance. In this sense Bcl6 acts probably mostly during the fate transition itself, and could provide a mechanism for the progressive restriction from extrinsic to intrinsic cues that has been long described following neuronal differentiation (Edlund and Jessell, 1999) , in line with the described expression pattern of Bcl6 that gets gradually upregulated as neural progenitors undergo neuronal differentiation (Tiberi et al., 2014; Tiberi et al., 2012a ). This molecular logic could also partially ensure that neuronal differentiation takes place irreversibly, even in the presence of proliferative extrinsic cues, thus providing robustness to the neurogenesis process. In the same frame, as Bcl6 was previously found to act as an oncosuppressor in the cerebellum (Tiberi et al., 2014) , it will be interesting to test whether this effect may be linked to a block of dedifferentiation in this or other neural cell types, as shown for the transcriptional repressor Lola in the fly nervous system (Southall et al., 2014 in the frontal cortex (Tiberi et al., 2012a) . Indeed, it has been suggested that the specification of the cortex topology could rely in part on rostro-caudal and latero-medial gradients of the cell-cycle G1 phase duration and neurogenesis (Miyama et al., 1997) , to which Bcl6 could contribute to in a major way, given its preferential expression in the frontal cortex, and its effects on signaling cues, such as Wnts and FGFs that can also impact on cortical areal patterning (Sur and Rubenstein, 2005; Tiberi et al., 2012a) .
From a molecular viewpoint, Bcl6 appears to act through the same generic mechanism on most if not all of its targets, i.e. direct repression and Sirt1 recruitment, together with histone deacetylation that is correlated with decreased transcription. However some aspects of Bcl6 function are also pathway-specific, such as the regulation of Tcf7I1 on Ccnd1/2 genes. It will be interesting to determine the underlying precise mechanism, and whether Bcl6 regulates other pathway-specific transcription factors in a similar way.
To sum up, our data support a model whereby a single intrinsic factor downregulates the responsiveness to extrinsic cues, through transcriptional repression at multiple parallel and serial levels along the downstream pathways, to ensure irreversible neurogenic fate transition. Our data thus uncover a novel and elegant mechanism that controls the neurogenic transition, and establish an important molecular link between transcriptional repression and robustness of neural fate conversion. As Bcl6 is expressed in only specific subsets of progenitors and neurons during brain development, future work should determine whether other transcriptional repressors in distinct parts of the nervous system can similarly contribute to neurogenic fate transition. 
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identifies TGF-beta/BMP-ER stress pathways as key regulators of neural-and malignant glioma-stem cell homeostasis. The plug date was defined as embryonic day E0.5. For experiments using
Bcl6
-/-mice, we mated Bcl6 +/− mice (mixed C57BL/6 and CD1 background), in which the null allele lacked exons 4-10 (Ye et al., 1997).
Plasmids. The Ccnd1 coding sequences (888 bp) and the Ccnd2 5'UTR+coding sequence (1145 bp) were amplified by PCR from ESC-derived cortical progenitor cDNA, and the sequences verified and cloned into pGEMT plasmid (Promega). The Axin2 plasmid was a kind gift from Dr Isabelle Garcia (ULB).
The Bcl6 coding sequence was amplified by PCR from cDNA and cloned into pCAG-IRES-GFP (pCIG). The pCAG-Δ 90Ctnnb1 plasmid (N-terminal deletion lacking GSK3-dependent S 33 , S 37 and T 41 phosphorylation sites) was obtained from Addgene (plasmid #26645). shRNA plasmids were cloned downstream of the U6 promoter into the pSilencer2.1-CAG-Venus (pSCV2)-plasmid as previously described (Tiberi et al., 2012a) with the exception of the Ctnnb1 shRNA plasmid (pLKO.1-puro vector, Sigma). Target sequences were 5'-ACTACCGTTGTTATAGGTG-3' (Control; (Tiberi et al., 2012a) , 5'-TGATGTTCTTCTCAACCTTAA-3' (Bcl6; (Tiberi et al., 2012a; Zhang et al., 2007) , CGACTTCAAGTTTGCCATGTA-3' (Ccnd2; (Gargiulo et al., 2013) and were previously validated.
In Utero Electroporation. Timed-pregnant mice were anesthetized with a ketamine/xylazine mixture at E13.5. Each uterus was cautiously exposed under sterile conditions. Fast-green (Sigma)-labeled plasmid solutions were prepared using either 1 µg/µL or 0.5 µg/µL of appropriate DNA combinations for gain of function experiments or knockdown experiments, respectively.
DNA solutions were injected into the lateral ventricles of the embryos using a heat-pulled glass capillary (1.0 OD x 0.78 x 100 L mm; Harvard Apparatus) prepared with a heat micropipette puller (heat: 580, pull: 100, velocity: 170, time: 120, pressure: 500; . Electroporation was performed using tweezers electrodes (Nepa Gene CUY650P5) connected to a BTX830 electroporator (5 pulses of 30 V for 100 ms with an interval of 1 s).
Embryos were placed back into the abdominal cavity, and mice were sutured and placed on a heating plate until recovery.
Immunofluorescence. Embryos were fixed by transcardiac perfusion with freshly-prepared 4% paraformaldehyde (Invitrogen). Brains were dissected, and 100 mm sections were prepared using a Leica VT1000S vibrosector.
Slices were transferred into PBS with 0.5 µg/mL sodium azide (Sigma), then blocked with PBS supplemented with 3% horse serum (Invitrogen) and 0.3% For differentiation, A2 lox.Cre Bcl6 mouse ESCs were plated at low density (20 × 10 3 ml −1 ) on gelatin-coated coverslips and cultured as previously described (Gaspard et al., 2009) . Briefly, on day 0 of the differentiation, the ES medium was changed to DDM medium. At day 2, DDM was supplemented with cyclopamine (400 ng/mL, Calbiochem) and the medium was replenished every 2 days. After 10 days, medium was switched back to DDM. Doxycline treatment (1 µg.ml −1 ) for Bcl6 induction or DMSO (1:1000, control) was applied for 12-24 h at day 12. CHIR99021 (4 µM, Tocris) needed to be applied for 48h, i.e. from day 10, to effectively impact Wnt target genes.
Transcriptome analyses. Total mRNA from four independent samples from ESc-derived cortical differentiations (day 12 ± doxycycline) was extracted using the QIAGEN RNeasy mini kit according to the manufacturer's recommendations. Following RNA quality control assessed on a Bioanalyzer 2100 (Agilent technologies), the indexed cDNA libraries were prepared using the TruSeq stranded mRNA Library Preparation kit (Illumina) following manufacturer's recommendations. The multiplexed libraries (18 pM) were loaded on flow cells and sequences were produced using a HiSeq PE Cluster revealed no specific staining (data not shown). Littermate embryos were compared using 3 animals/genotype from 3 different litters for Axin2 and Ccnd2 or 6 embryos/genotype from 4 different litters (Ccnd1). Images were acquired with a Zeiss Axioplan 2 microscope and a Spot RT3 camera using the Spot 5.2 software. Quantifications of gray densities were done on comparable levels of the dorsal primordium of the frontal cortex using ImageJ software (Schindelin et al., 2012) .
Chromatin Immunoprecipitation. A2 lox.Cre Bcl6 cells and E12.5 Bcl6 WT and KO telencephalons were fixed with 1% formaldehyde in phosphatebuffered saline and then lysed, sonicated, and immunoprecipitated as described previously (Castro et al., 2011) . Immunoprecipitations were performed using IgG isotype control (ab171870, Abcam), Bcl6 (sc-858, Santa
Cruz Biotechnology), H1.4K26ac (H7789, Sigma-Aldrich), H4K16ac (07-329, Millipore), Sirt1 (07-131, Millipore), and Tcf7l1 (kind gift from Prof. Brad Merrill) rabbit antibodies and 50/50 mixed protein A and protein G magnetic Dynabeads (ThermoFisher Scientific). Primers used for ChIP-qPCR were designed to surround the predicted Bcl6 matrices present in the significant peaks of the ChIP-seq screen and are listed in the Supplementary Table S4 .
ChIP-seq. Following chromatin immunoprecipitation using A2 lox.Cre Bcl6 cells (differentiation day 12, 24h Bcl6 induction using 1 µg.ml −1 Doxycline treatment) as described above, ChIP libraries were prepared according to the standard Illumina ChIP-seq protocol and were sequenced with the Genome Analyzer IIx (Illumina) as previously described (Mateo et al., 2015) . Reads GO analysis was performed using the GOrilla software (http://cblgorilla.cs.technion.ac.il). C -3 -2 -1 0 1 2 3 5 6
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